Trust is emerging as a strategic currency in healthcare. As digital transformation accelerates across hospitals, insurers, and life sciences, the ability to manage consent and preference data is becoming a key differentiator for organizations aiming to deliver personalized care, maintain compliance, and drive commercial growth.
Jump to:
- Trust begins with consent
- Consent as a strategic control
- Preference data enables personalized care
- Regulatory complexity and operational impact
- Technology strategy and future readiness
- Enabling strategy with technology
- Trust is the foundation of digital health transformation
Trust begins with consent
Healthcare organizations are collecting more data than ever before. From electronic health records and telemedicine platforms to AI-powered diagnostics and wearable technologies, the volume and sensitivity of data is increasing rapidly – raising the question: who controls the data, and how is consent managed?
92% of Americans believe explicit opt-in consent should be mandatory for sharing health data. Despite this, 72% still worry about how their information might be used by third parties (Prescribing privacy: Patient health data research report). The gap between expectation and reality is widening – and it’s creating both risk and opportunity. Healthcare organizations that take consent and preference management seriously are earning trust, building loyalty, and reducing churn by showing patients they’re in control.
The World Economic Forum highlights how ethical data stewardship is central to unlocking the full potential of digital health. When patients trust how their data is handled, innovation follows.
Consent as a strategic control
In an interview with McKinsey, Matt Holt at New Mountain Capital explains that privacy and consent are no longer just legal obligations, they are central to how healthcare organizations build trust and scale responsibly. He notes that “consent is the control point for data activation,” and that organizations must treat it as a foundational element of their digital strategy.
Consent is also becoming a key enabler of interoperability. Initiatives like the U.S. Office of the National Coordinator for Health Information Technology’s Trusted Exchange Framework and Common Agreement (TEFCA) are pushing for standardized, secure data sharing across systems. Without clear and auditable consent, these efforts risk undermining patient trust and regulatory compliance.
Preference data enables personalized care
The care continuum is shifting toward awareness, education, and preventive care. These areas require early and sustained digital engagement. Preference data plays a vital role in enabling tailored communications, reducing noise, and improving patient experience.
For example, Blue Cross Blue Shield of Arizona saw a 46–55% increase in members opting for electronic communications after implementing a consent and preference strategy. This reduced operational costs and improved engagement, demonstrating the commercial value of scalable consent management across marketing, CRM, compliance, and customer service.
Regulatory complexity and operational impact
Regulatory complexity is increasing. HIPAA, HITECH, GDPR, and emerging state laws such as Washington’s My Health, My Data Act are reshaping the privacy landscape. The latter introduces new obligations for entities handling consumer health data, including geofencing restrictions and heightened consent requirements.
In the United Kingdom, the Information Commissioner’s Office (ICO) continues to enforce strict standards around data transparency and lawful processing under the UK GDPR. Healthcare organizations must ensure that consent is freely given, specific, informed, and unambiguous. Failure to meet these standards can result in reputational damage and financial penalties.
Consent infrastructure helps mitigate these risks by providing real-time audit trails, configurable workflows, and automated compliance reporting, reducing the burden on internal teams and supports scalable governance across departments.
Technology strategy and future readiness
Investing in consent and preference infrastructure is a strategic decision that supports long-term innovation. Consent enables responsible data activation, supports AI-driven personalization, and prepares organizations for future regulatory shifts.
For example, the European Health Data Space (EHDS) initiative aims to create a unified framework for sharing health data across EU member states. Organizations that have already implemented scalable consent solutions will be better positioned to participate in cross-border data exchanges.
In addition, Consent infrastructure supports integration with identity and access management (IAM) systems, enabling secure authentication and verification across digital touchpoints, as healthcare moves toward omnichannel engagement and virtual care delivery.
Enabling strategy with technology
Consent management platforms (CMPs) are designed to operationalize these strategies. Platforms like Cassie, developed by Syrenis, help healthcare organizations:
- Centralize consent across fragmented systems
- Honor granular patient preferences
- Ensure real-time auditability and regulatory compliance
- Activate data in a trusted and consented manner
As Lisa Brzycki, Cybersecurity & Risk Executive at Eli Lilly, explains, CMPs support data activation in a consented way that enhances personalization and builds customer trust.
Trust is the foundation of digital health transformation
As healthcare organizations accelerate their digital strategies, trust, built through transparent consent and preference management, is emerging as a core enabler of innovation, compliance, and patient engagement. Consent is a strategic control point that governs data activation, supports interoperability, and ensures lawful processing across jurisdictions. Preference data, meanwhile, empowers personalized care and strengthens long-term relationships.
Platforms like Cassie by Syrenis allow healthcare leaders to operationalize trust, activate data responsibly, and future-proof their organizations against evolving regulatory and technological landscapes. In a sector where patient trust drives outcomes, consent and preference data are not just operational tools – they are the currency of sustainable growth.
